COVID-19 and rhino-orbital mucormycosis – a case report
Open Access
- 5 October 2021
- journal article
- Published by Heighten Science Publications Corporation in Journal of Pulmonology and Respiratory Research
- Vol. 5 (1), 094-096
- https://doi.org/10.29328/journal.jprr.1001032
Abstract
There is a constant rise in cases of rhino-orbital mucormycosis in people with Coronavirus disease 2019 (COVID-19). Generally, Mucormycosis develops in immunosuppression or debilitating diseases. In cases having head and neck involvement, the mold enters the respiratory tract with further involvement of nose and sinuses and there is consecutive progression into orbital and intracranial structures. Diabetes Mellitus (DM) is an independent risk factor for both severe COVID-19 and mucormycosis. The clinical examination and direct smears are helpful for early diagnosis of the disease and timely intervention. For the better prevention and management of such opportunistic infections in COVID-19 patients, it is prudent to establish prophylactic treatment protocols along with rational use of corticosteroids. We here report a case of Rhino-orbital Mucormycosis infection caused by Rhizopus oryzae in a COVID-19 patient with Diabetes Mellitus.Keywords
This publication has 6 references indexed in Scilit:
- Mucormycosis with orbital compartment syndrome in a patient with COVID-19The American Journal of Emergency Medicine, 2020
- Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomyEnvironmental Research, 2020
- Invasive and Non-Invasive Fungal Rhinosinusitis—A Review and Update of the EvidenceMedicina, 2019
- Mucormycosis: Battle with the Deadly Enemy over a Five-Year Period in IndiaJournal of Fungi, 2018
- Perineural spread of rhino-orbitocerebral mucormycosis caused by Apophysomyces elegansAnnals of Indian Academy of Neurology, 2013
- Rhino‐Orbital and Rhino‐Orbito‐Cerebral MucormycosisOtolaryngology -- Head and Neck Surgery, 2002